Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
basiliximab interleukin 2 receptor alpha NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]		 8.05 approved antibody
basiliximab interleukin-2 receptor subunit alpha biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]		 8.05 approved,investigational antibody
basiliximab interleukin 2 receptor alpha NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]		 8.05 approved inhibitor
basiliximab interleukin-2 receptor subunit alpha biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]		 8.05 approved,investigational antibody,inhibitor
basiliximab interleukin 2 receptor alpha NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]		 8.05 approved unknown
basiliximab interleukin-2 receptor subunit beta biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Transplanted organ[MeSHID:D019737]		 24.75 approved,investigational antibody,inhibitor
click here to return to the previous page